{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T12:12:06Z","timestamp":1783512726485,"version":"3.55.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"41","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,8,29]],"date-time":"2018-08-29T00:00:00Z","timestamp":1535500800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000199","name":"U.S. Department of Agriculture","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000199","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000199","name":"USDA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000199","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010345","name":"ARS","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010345","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000199","name":"USDA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000199","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.vaccine.2018.08.072","type":"journal-article","created":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T18:28:56Z","timestamp":1535826536000},"page":"6103-6110","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["The type of adjuvant in whole inactivated influenza a virus vaccines impacts vaccine-associated enhanced respiratory disease"],"prefix":"10.1016","volume":"36","author":[{"given":"Carine K.","family":"Souza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela S.","family":"Raj\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew R.","family":"Sandbulte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola S.","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Crystal L.","family":"Loving","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillip C.","family":"Gauger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy L.","family":"Vincent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2018.08.072_b0005","first-page":"91","article-title":"Pandemic H1N1 in the United States resulted in influenza a viruses with diverse genetic constellations with variable virulence in pigs","volume":"2017","author":"Rajao","year":"2009","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2018.08.072_b0010","doi-asserted-by":"crossref","first-page":"e12217","DOI":"10.7554\/eLife.12217","article-title":"The global antigenic diversity of swine influenza A viruses","volume":"5","author":"Lewis","year":"2016","journal-title":"eLife"},{"key":"10.1016\/j.vaccine.2018.08.072_b0015","first-page":"1","article-title":"A phylogeny-based global nomenclature system and automated annotation tool for H1 hemagglutinin genes from swine influenza a viruses","author":"Anderson","year":"2016","journal-title":"mSphere"},{"key":"10.1016\/j.vaccine.2018.08.072_b0020","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1126\/science.1176225","article-title":"Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans","volume":"325","author":"Garten","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2018.08.072_b0025","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.tim.2014.12.002","article-title":"Reverse zoonosis of influenza to swine: new perspectives on the human-animal interface","volume":"23","author":"Nelson","year":"2015","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.vaccine.2018.08.072_b0030","doi-asserted-by":"crossref","first-page":"4752","DOI":"10.1128\/JVI.03805-13","article-title":"Substitutions near the hemagglutinin receptor-binding site determine the antigenic evolution of influenza A H3N2 viruses in U.S. swine","volume":"88","author":"Lewis","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2018.08.072_b0035","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1136\/vr.101741","article-title":"Haemagglutinin and nucleoprotein replicon particle vaccination of swine protects against the pandemic H1N1 2009 virus","volume":"173","author":"Vander Veen","year":"2013","journal-title":"Vet Rec"},{"key":"10.1016\/j.vaccine.2018.08.072_b0040","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/irv.12531","article-title":"Live attenuated influenza virus vaccine reduces virus shedding of newborn piglets in the presence of maternal antibody","volume":"12","author":"Genzow","year":"2018","journal-title":"Influenza Other Respir Viruses"},{"key":"10.1016\/j.vaccine.2018.08.072_b0045","article-title":"Swine influenza virus vaccines: to change or not to change-that's the question","volume":"173\u2013200","author":"Van Reeth","year":"2013","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2018.08.072_b0050","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1016\/j.vaccine.2010.01.049","article-title":"Efficacy of inactivated swine influenza virus vaccines against the 2009 A\/H1N1 influenza virus in pigs","volume":"28","author":"Vincent","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.08.072_b0055","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1016\/j.vaccine.2011.01.082","article-title":"Enhanced pneumonia and disease in pigs vaccinated with an inactivated human-like (delta-cluster) H1N2 vaccine and challenged with pandemic 2009 H1N1 influenza virus","volume":"29","author":"Gauger","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.08.072_b0060","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1177\/0300985812439724","article-title":"Kinetics of lung lesion development and pro-inflammatory cytokine response in pigs with vaccine-associated enhanced respiratory disease induced by challenge with pandemic (2009) A\/H1N1 influenza virus","volume":"49","author":"Gauger","year":"2012","journal-title":"Vet Pathol"},{"key":"10.1016\/j.vaccine.2018.08.072_b0065","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1089\/vim.2013.0018","article-title":"Vaccine-associated enhanced respiratory disease does not interfere with the adaptive immune response following challenge with pandemic A\/H1N1 2009","volume":"26","author":"Gauger","year":"2013","journal-title":"Viral Immunol"},{"key":"10.1016\/j.vaccine.2018.08.072_b0070","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1099\/jgv.0.000468","article-title":"Vaccine-associated enhanced respiratory disease is influenced by haemagglutinin and neuraminidase in whole inactivated influenza virus vaccines","volume":"97","author":"Rajao","year":"2016","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2018.08.072_b0075","doi-asserted-by":"crossref","first-page":"5170","DOI":"10.1016\/j.vaccine.2014.07.059","article-title":"Influenza A virus hemagglutinin protein subunit vaccine elicits vaccine-associated enhanced respiratory disease in pigs","volume":"32","author":"Rajao","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.08.072_b0080","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1128\/CVI.00563-15","article-title":"Age at vaccination and timing of infection do not alter vaccine-associated enhanced respiratory disease in influenza a virus-infected pigs","volume":"23","author":"Souza","year":"2016","journal-title":"Clin Vaccine Immunol: CVI"},{"key":"10.1016\/j.vaccine.2018.08.072_b0085","doi-asserted-by":"crossref","first-page":"200ra114","DOI":"10.1126\/scitranslmed.3006366","article-title":"Vaccine-induced anti-HA2 antibodies promote virus fusion and enhance influenza virus respiratory disease","volume":"5","author":"Khurana","year":"2013","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.vaccine.2018.08.072_b0090","doi-asserted-by":"crossref","DOI":"10.4414\/smw.2014.13940","article-title":"Vaccine adjuvants\u2013understanding molecular mechanisms to improve vaccines","volume":"144","author":"Egli","year":"2014","journal-title":"Swiss Medical Weekly"},{"issue":"3","key":"10.1016\/j.vaccine.2018.08.072_b0095","doi-asserted-by":"crossref","first-page":"320","DOI":"10.3390\/vaccines3020320","article-title":"Vaccine adjuvants: from 1920 to 2015 and beyond","author":"Di Pasquale","year":"2015","journal-title":"Vaccines"},{"key":"10.1016\/j.vaccine.2018.08.072_b0100","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.biologicals.2009.02.002","article-title":"On the relationship between mean antibody level, seroprotection and clinical protection from influenza","volume":"37","author":"Nauta","year":"2009","journal-title":"Biol: J Int Assoc Biol Standardization"},{"key":"10.1016\/j.vaccine.2018.08.072_b0105","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1128\/JVI.02843-13","article-title":"Human cytotoxic T lymphocytes directed to seasonal influenza A viruses cross-react with the newly emerging H7N9 virus","volume":"88","author":"van de Sandt","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2018.08.072_b0110","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1099\/0022-1317-82-11-2697","article-title":"Respiratory and systemic humoral and cellular immune responses of pigs to a heterosubtypic influenza A virus infection","volume":"82","author":"Heinen","year":"2001","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2018.08.072_b0115","doi-asserted-by":"crossref","first-page":"10597","DOI":"10.1128\/JVI.01439-12","article-title":"Live attenuated influenza vaccine provides superior protection from heterologous infection in pigs with maternal antibodies without inducing vaccine-associated enhanced respiratory disease","volume":"86","author":"Vincent","year":"2012","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2018.08.072_b0120","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1750-2659.2009.00121.x","article-title":"Experimental inoculation of pigs with pandemic H1N1 2009 virus and HI cross-reactivity with contemporary swine influenza virus antisera","volume":"4","author":"Vincent","year":"2010","journal-title":"Influenza Other Respir Viruses"},{"key":"10.1016\/j.vaccine.2018.08.072_b0125","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.vetmic.2007.07.011","article-title":"Failure of protection and enhanced pneumonia with a US H1N2 swine influenza virus in pigs vaccinated with an inactivated classical swine H1N1 vaccine","volume":"126","author":"Vincent","year":"2008","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2018.08.072_b0130","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.vetimm.2006.02.008","article-title":"The immune response and maternal antibody interference to a heterologous H1N1 swine influenza virus infection following vaccination","volume":"112","author":"Kitikoon","year":"2006","journal-title":"Vet Immunol Immunopathol"},{"key":"10.1016\/j.vaccine.2018.08.072_b0135","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/oxfordjournals.aje.a118408","article-title":"A simple method of estimating fifty per cent endpoints","volume":"27","author":"Reed","year":"1938","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2018.08.072_b0140","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/978-1-4939-0758-8_24","article-title":"Hemagglutinin inhibition assay with swine sera","volume":"1161","author":"Kitikoon","year":"2014","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.vaccine.2018.08.072_b0145","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/978-1-4939-0758-8_25","article-title":"Enzyme-linked immunosorbent assay for detection of serum or mucosal isotype-specific IgG and IgA whole-virus antibody to influenza A virus in swine","volume":"1161","author":"Gauger","year":"2014","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.vaccine.2018.08.072_b0150","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.1016\/j.vaccine.2016.06.001","article-title":"Neuraminidase inhibiting antibody responses in pigs differ between influenza A virus N2 lineages and by vaccine type","volume":"34","author":"Sandbulte","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.08.072_b0155","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.vetimm.2017.01.009","article-title":"Factors affecting induction of peripheral IFN-gamma recall response to influenza A virus vaccination in pigs","volume":"185","author":"Olson","year":"2017","journal-title":"Vet Immunol Immunopathol"},{"key":"10.1016\/j.vaccine.2018.08.072_b0160","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1126\/science.1097211","article-title":"Mapping the antigenic and genetic evolution of influenza virus","volume":"305","author":"Smith","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2018.08.072_b0165","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1126\/science.1256427","article-title":"Antibody landscapes after influenza virus infection or vaccination","volume":"346","author":"Fonville","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2018.08.072_b0170","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1099\/vir.0.027557-0","article-title":"Genetic and antigenic characterization of H1 influenza viruses from United States swine from 2008","volume":"92","author":"Lorusso","year":"2011","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2018.08.072_b0175","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1016\/j.vaccine.2006.12.018","article-title":"The utility of ISCOMATRIX adjuvant for dose reduction of antigen for vaccines requiring antibody responses","volume":"25","author":"Boyle","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.08.072_b0180","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1016\/S0264-410X(00)00498-9","article-title":"Adjuvants designed for veterinary and human vaccines","volume":"19","author":"Aucouturier","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.08.072_b0185","doi-asserted-by":"crossref","first-page":"15ra5","DOI":"10.1126\/scitranslmed.3000624","article-title":"Vaccines with MF59 adjuvant expand the antibody repertoire to target protective sites of pandemic avian H5N1 influenza virus","volume":"2","author":"Khurana","year":"2010","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.vaccine.2018.08.072_b0190","doi-asserted-by":"crossref","first-page":"85ra48","DOI":"10.1126\/scitranslmed.3002336","article-title":"MF59 adjuvant enhances diversity and affinity of antibody-mediated immune response to pandemic influenza vaccines","volume":"3","author":"Khurana","year":"2011","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.vaccine.2018.08.072_b0195","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.provac.2010.03.003","article-title":"Microgel particulate adjuvant: characterisation and mechanisms of action","volume":"2","author":"Vialle","year":"2010","journal-title":"Procedia Vaccinol"},{"key":"10.1016\/j.vaccine.2018.08.072_b0200","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.provac.2009.07.026","article-title":"Adjuvant formulation for veterinary vaccines: Montanide\u2122 Gel safety profile","volume":"1","author":"Parker","year":"2009","journal-title":"Procedia Vaccinol"},{"key":"10.1016\/j.vaccine.2018.08.072_b0205","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.virol.2016.01.015","article-title":"Heterologous challenge in the presence of maternally-derived antibodies results in vaccine-associated enhanced respiratory disease in weaned piglets","volume":"491","author":"Rajao","year":"2016","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2018.08.072_b0210","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.virol.2014.10.003","article-title":"Live attenuated influenza A virus vaccine protects against A(H1N1)pdm09 heterologous challenge without vaccine associated enhanced respiratory disease","volume":"471\u2013473","author":"Gauger","year":"2014","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2018.08.072_b0215","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1093\/infdis\/jiu334","article-title":"Cross-reactive influenza-specific antibody-dependent cellular cytotoxicity in intravenous immunoglobulin as a potential therapeutic against emerging influenza viruses","volume":"210","author":"Jegaskanda","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2018.08.072_b0220","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0017377","article-title":"A protective role for complement C3 protein during pandemic 2009 H1N1 and H5N1 influenza A virus infection","volume":"6","author":"O'Brien","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2018.08.072_b0225","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1086\/517398","article-title":"Bronchoalveolar interferon-alpha, tumor necrosis factor-alpha, interleukin-1, and inflammation during acute influenza in pigs: a possible model for humans?","volume":"177","author":"Van Reeth","year":"1998","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2018.08.072_b0230","article-title":"Broad cross-reactive IgG responses elicited by adjuvanted vaccination with recombinant influenza hemagglutinin (rHA) in ferrets and mice","volume":"13","author":"Wang","year":"2018","journal-title":"PLoS One"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1831212X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1831212X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:28:49Z","timestamp":1759400929000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X1831212X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":46,"journal-issue":{"issue":"41","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S0264410X1831212X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.08.072","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The type of adjuvant in whole inactivated influenza a virus vaccines impacts vaccine-associated enhanced respiratory disease","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.08.072","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}